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Summary. Small quantities of low-molecular weight peptides have been characterized in the feces of axenic mice. In fecal material of axenic mice fed an autoclaved synthetic (SN) diet, we isolated a dipeptide and characterized its structure as f3-aspartyl-¡;-lysine. This product was also present in the feces of gnotobiotic mice harbouring Clostridium perenne. We could not detect the product in the fecal contents of holoxenic mice, Clostridium diffici/e-contaminated mice or axenic mice fed the irradiated SN diet.
The peptide, fl-aspartyl-E -lysine, was produced by heating proteins during sterilization, causing the formation of a pseudopeptide bond between the e-amino group of lysine and the amide group of asparagine. The intestinal strains seemed to differ in their ability to split this pseudopeptide bond in vivo.
Introduction.
The fecal microbial flora of newborn mammals seems to depend largely on their diet, which varies between birth and weaning (Decuypere and Van Der Heyde, 1972 ; Chopin et al., 1974 ; Ducluzeau et al., 1974 ; Savage, 1977 (Dubos, 1982) . The present paper describes the isolation and characterization of a low-molecular weight peptide in the inhibitory fraction of the fecal contents of axenic mice fed a nonpermissive diet. We have also tried to determine if the presence of this peptide in the gut depended on the bacterial strain harboured. The effect of this peptide on the growth of C. perenne has been studied by Dubos (1982 asparagine. Nevertheless, the molecular weight of the peptide, determined by mass spectrometry, indicated that it contained aspartic acid. As the N-terminal residue identified by dansyl chloride reaction was aspartic acid, we might expect the structure of the peptide to be aspartyl lysine. As our peptide migrated as commercial a-aspartyl c-lysine, and not as commercial aaspartyl a-lysine, it could be concluded that a pseudopeptide bond involving the 8 -amino group of lysine was present.
These data do not clearly demonstrate whether the aspartic acid was engaged with its carboxyl function in the a or the 0 position. As electrophoretic mobility of the dipeptide, aspartylglycine, was the same in both cases ( fig. 3) , the carboxyl function of the aspartic acid engaged in the bond could not be identified. Neither could we, as Welling and Groen (1978) did, determine this function from the colour obtained with ninhydrin since all the Asp-Lys dipeptides gave identical staining, probably due to the free amino group of lysine.
Origin of the peptide. &horbar; As the feces of axenic mice fed the protein-free diet did not contain our peptide, we supposed that the peptide had been released from the protein diet by endogenous proteolytic enzymes in the digestive tract during digestion and that because of the pseudopeptide bond, the animals could not absorb the product, which was eliminated in the feces.
A comparison of the two sterilization techniques, i.e. heat and irradiation, showed important differences in the peptide contents of the feces of axenic mice. When the diet was heated, large quantities of the product were obtained ; when it was irradiated, with little heat, we only obtained small amounts in the feces. We thus suppose that the presence of the peptide in the feces was to due heating. Pisano et al. (1960) and Asquith et al. (1970) detected the presence of f :-ly-glutamyl) lysine in heated fibrin and keratins. E ;-N-(¡3-L-aspartyl) L-lysine is also suggested by Asquith et al. (1970) in the same products. Bjarnason and Carpenter (1970) showed that, owing to a reaction between the E -amino group of lysine and the amine group of asparagine, heating proteins causes the formation of a pseudopeptide bond. These results would indicate that our dipeptide was produced by such a reaction between asparagine and lysine when the proteins of the SN diet were heated. Therefore, we suggest that the structure of our peptide is 13-L -aspa rtyl-E -L -Iysi ne.
Effect of bacterial strains. &horbar; The presence of a complex microflora in the gut caused the peptide to disappear from the fecal content as observed for aspartylglycine (Welling et al., 1980) . But 
